论文部分内容阅读
目的:探讨肺炎支原体感染诱发小儿哮喘的临床分析方法:选取从2016年5月至12月因肺炎支原体感染诱发哮喘和非肺炎支原体感染诱发哮喘患儿60例,随机分为观察组和常规组,30例/组。常规组患儿采用阿奇霉素和克拉霉素进行治疗;观察组患儿在常规组治疗方法基础上再予以喘乐宁进行联合治疗,对比两组治疗结果。结果:两组患儿在采用不同治疗方法后,都有明显改善,但两组治疗后病情复发情况进行比较,观察组患儿在抗体阳性率、复发率以及复发时间等方面明显优于常规组,差异明显具有统计学意义(P<0.05)。结论:因肺炎支原体感染诱发的小儿哮喘具有不同的临床症状,根据其具体病因对患儿应用阿奇霉素、克拉霉素以及其他抗生素药物进行针对性治疗,效果显著。
Objective: To investigate the clinical analysis of Mycoplasma pneumoniae infection-induced pediatric asthma.Methods: Sixty children with asthma induced by Mycoplasma pneumoniae infection and non-Mycoplasma pneumoniae infection from May to December in 2016 were randomly divided into observation group and routine group, 30 cases / group. The patients in the routine group were treated with azithromycin and clarithromycin. The observation group was treated with salbutamol on the basis of the conventional treatment, and the treatment results were compared between the two groups. Results: The two groups of children treated with different methods have significantly improved, but the two groups after treatment compared the recurrence of the situation, the observation group of patients in the antibody positive rate, recurrence rate and recurrence time was significantly better than the conventional group , The difference was statistically significant (P <0.05). Conclusion: Mycoplasma pneumonia caused by Mycoplasma pneumoniae infection have different clinical symptoms, according to their specific causes of azithromycin, clarithromycin and other antibiotics in children for targeted treatment, the effect is significant.